Cargando…
The Efficacy and Adverse Events in Patients with Head and Neck Cancer Following Radiotherapy Combined with S-1 Therapy: A Meta-Analysis
SIMPLE SUMMARY: Head and neck squamous cell carcinoma (HNSCC) ranks sixth among the most common cancers, accounting for approximately 3.3% of all cancer cases. While HNSCC was generally treated with postoperative concurrent chemo-radiotherapy, traditional chemotherapy agents often lead to multiple s...
Autores principales: | Shih, Hung-Sheng, Jhou, Hong-Jie, Ou, Yang-Hao, Liu, Yen-Tze, Kor, Chew-Teng, Chen, Andy Wei-Ge, Chen, Mu-Kuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231857/ https://www.ncbi.nlm.nih.gov/pubmed/34199326 http://dx.doi.org/10.3390/cancers13122971 |
Ejemplares similares
-
Relationship between Preoperative Nutritional Status and Clinical Outcomes in Patients with Head and Neck Cancer
por: Wang, En-Ying, et al.
Publicado: (2022) -
Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy
por: Niska, Joshua R., et al.
Publicado: (2020) -
Otolaryngology, Head and Neck Surgery
por: Yang, Tsung-Lin, et al.
Publicado: (2014) -
Adaptive radiotherapy for head and neck cancer
por: Morgan, Howard E., et al.
Publicado: (2020) -
Oral complications of radiotherapy in the head and neck
por: Jham, Bruno Correia, et al.
Publicado: (2015)